2m 2m 2m 2m 2m 2m 2m
Enovis (ENOV)
NYSE
$21.68+$0.38 (+1.76%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.2BMarket Cap
- -28.91%1-Year Change
- Medical DevicesIndustry
Enovis (ENOV)
$21.68+$0.38 (+1.76%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.2B +6.66% | 2.1B +23.46% | 1.7B +8.61% | 1.6B -59.22% | |
Cost of Revenue | 902.8M -2.60% | 926.9M +29.38% | 716.4M +3.27% | 693.7M -69.04% | |
Gross Profit | 1.3B +13.93% | 1.2B +19.17% | 990.8M +13.96% | 869.4M -46.12% | |
Sales and Marketing Expense | 1.1B +4.17% | 1.0B +23.73% | 830.3M +7.43% | 772.9M -41.86% | |
Research and Development Expense | -120.3M +31.80% | -91.3M +21.20% | -75.3M +23.84% | -60.8M -31.50% | |
Depreciation and Amortization Expense | 294.4M +3.36% | 284.8M +31.18% | 217.1M -1.18% | 219.7M -16.43% | |
Total Operating Expenses | 902.8M -2.60% | 926.9M +29.38% | 716.4M +3.27% | 693.7M -69.04% | |
Operating Profit | -1.1B +44.93% | -775.7M +1,080.54% | -65.7M -7.68% | -71.2M -127.73% | |
Interest Income | 900,000 +50.00% | 600,000 +200.00% | 200,000 -90.42% | 2.1M +106.99% | |
Interest Expense | -34.8M -39.01% | -57.1M +189.13% | -19.7M -17.89% | -24.1M -66.87% | |
Interest Income and Expense and Net | -33.9M -39.96% | -56.5M +189.02% | -19.5M -11.00% | -22.0M -78.56% | |
Total Nonoperating Income and Expense | -367,000 -103.71% | 9.9M -61.44% | 25.7M +1,129.07% | 2.1M -97.12% | |
Income before Taxes | -1.2B +40.89% | -822.9M +1,125.90% | -67.1M +3,144.47% | -2.1M -101.25% | |
Income Taxes | 22.3M +396.28% | 4.5M +133.80% | -13.3M -136.79% | 36.1M -45.84% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 1.6M N/A | |
Net Income | -1.2B +43.48% | -825.5M +2,381.87% | -33.3M +150.23% | -13.3M -118.55% | |
Net Income from Continuing Operations Applicable to Common | -1.2B +42.82% | -827.4M +1,436.83% | -53.8M +40.98% | -38.2M -138.69% | |
Basic EPS and Net Income | -20.75 +38.98% | -14.93 +2,347.54% | -0.61 +144.00% | -0.25 -153.19% | |
Diluted EPS and Net Income | -20.75 +38.98% | -14.93 +2,347.54% | -0.61 +144.00% | -0.25 -154.35% | |
Basic Weighted Average Shares | 57.1M +3.23% | 55.3M +1.44% | 54.5M +0.79% | 54.1M -64.76% | |
Diluted Weighted Average Shares | 57.1M +3.23% | 55.3M +1.44% | 54.5M +0.79% | 54.1M -65.24% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 36.4M -24.45% | 48.2M +33.09% | 36.2M +48.96% | 24.3M -96.62% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 36.4M -24.45% | 48.2M +33.09% | 36.2M +48.96% | 24.3M -96.62% | |
Total Current Assets | 1.2B +5.29% | 1.1B +27.88% | 896.5M +12.77% | 795.0M -65.48% | |
Accumulated Depreciation | 396.8M +24.19% | 319.5M +31.79% | 242.4M +33.81% | 181.2M -54.03% | |
Property and Plant and Equipment and Net | 507.1M +25.36% | 404.5M +49.37% | 270.8M +14.39% | 236.7M -54.59% | |
Total Long-Term Assets | 93.3M +5.15% | 88.8M -1.64% | 90.3M +12.41% | 80.3M -77.91% | |
Total Assets | 3.8B -18.73% | 4.7B +4.64% | 4.5B +5.52% | 4.3B -49.82% | |
Income Taxes Payable | 27.2M +21.66% | 22.3M +55.31% | 14.4M +5.18% | 13.7M -81.08% | |
Total Short-Term Debt | 35.0M +74.76% | 20.0M N/A | 0 -100.00% | 219.3M +2,537.47% | |
Total Current Liabilities | 598.5M +13.13% | 529.0M +43.12% | 369.6M -34.61% | 565.2M -44.78% | |
Total Long-Term Debt | 1.3B -3.64% | 1.3B +180.90% | 466.2M +1,065.41% | 40.0M -98.08% | |
Total Long-Term Liabilities | 424.6M +61.12% | 263.5M +29.06% | 204.2M +22.27% | 167.0M -72.46% | |
Total Liabilities | 2.3B +8.74% | 2.2B +97.90% | 1.1B +32.20% | 823.4M -78.63% | |
Retained Earnings | -1.5B +418.50% | -283.0M -152.17% | 542.5M -5.78% | 575.7M -2.26% | |
Total Stockholders Equity | 1.5B -41.86% | 2.6B -25.04% | 3.4B -0.86% | 3.4B -25.32% | |
Total Shares Outstanding | 57.2M +2.36% | 55.9M +2.34% | 54.6M +0.68% | 54.2M -65.29% | |
Cash Flow | |||||
Cash from Operating Activities | 217.3M +91.44% | 113.5M -15.92% | 135.0M +341.65% | -55.9M -115.69% | |
Capital Expenditures | 197.4M +9.22% | 180.7M +47.86% | 122.2M +15.91% | 105.5M +1.16% | |
Cash from Investing Activities | -179.4M -81.23% | -955.5M +294.06% | -242.5M +37.46% | -176.4M -44.96% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -52.4M -106.19% | 846.8M +562.63% | 127.8M +127.48% | -465.1M -179.52% | |
Financials Ratio | |||||
Gross Margin | 59.84% +6.82% | 56.02% -3.47% | 58.04% +3.88% | 55.87% +33.44% | |
Operating Margin | -50.01% +35.87% | -36.81% +856.26% | -3.85% -15.00% | -4.53% -168.00% | |
Return on Assets | -27.69% +54.80% | -17.89% +2,262.15% | -0.76% +264.31% | -0.21% -123.02% | |
Return on Equity | -58.46% +111.78% | -27.61% +2,749.45% | -0.97% +193.93% | -0.33% -118.77% | |
Revenue Growth | 6.66% -71.59% | 23.46% +172.51% | 8.61% +114.54% | -59.22% -332.08% | |
Current Ratio | 2.02 -6.94% | 2.17 -10.65% | 2.43 +72.44% | 1.41 -37.49% | |
Cash Ratio | 0.06 -33.26% | 0.09 -6.95% | 0.10 +127.67% | 0.04 -93.88% | |
Debt-to-Equity Ratio | 0.87 +67.76% | 0.52 +280.43% | 0.14 +81.38% | 0.08 -83.36% | |
Debt-to-Assets Ratio | 0.34 +20.06% | 0.28 +172.44% | 0.10 +70.35% | 0.06 -75.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow